logo
Share SHARE
FONT-SIZE Plus   Neg

Deluxe Q1 Profit Rises

Deluxe Corp. (DLX) Thursday reported an increase in profit for the first quarter, due mainly to higher revenues.

The Shoreview, Minnesota-based company reported first-quarter net profit of $44.1 million or $0.86 per share, compared to $32.6 million or $0.63 per share last year.

Adjusted earnings for the quarter rose to $0. 88 per share from $0.75 per share in the prior-year quarter. On average, three analysts polled by Thomson Reuters expected the company to earn $0.79 per share for the quarter. Analysts' estimates typically exclude special items.

Total revenues for the quarter grew 8.1 percent to $378.0 million from $349.8 million in the prior-year quarter.

Looking ahead, the company expects second-quarter earnings in the range of $0.74 to $0.79 per share and adjusted earnings of $0.76 to $0.81 per share. Revenues for the second quarter are anticipated in the range of $353 million to $362 million. Analysts currently expect the company to earn $0.78 per share for the quarter.

The company increased its earnings guidance for the full-year 2012 to a range of $3.12 to $3.32 per share from previous estimate of $3.10 to $3.30 per share. The company also lifted its adjusted earnings guidance to a range of $3.20 to $3.40 per share, compared to prior estimate of $3.10 to $3.30 per share. Analysts currently expect the company to earn $3.21 per share for the quarter.

Deluxe now expects revenues for 2012 in the range of $1.45 billion to $1.48 billion compared to previous estimate of $1.42 billion to $1.46 billion.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Fast food giant McDonald's on Wednesday announced its global growth plan, targeting sales growth of 3-5% beginning in 2019. The company also highlighted its vision for new restaurants relying on technology such as self-ordering kiosks, curbside pick ups and partnerships with delivery services. At... Canadian drug-maker Valeant Pharmaceuticals International, Inc. on Tuesday reported a loss for the fourth quarter that widened from last year on a double-digit decline in revenues. However, both revenue and adjusted earnings beat analysts' estimates. Valeant also said it plans to relaunch its sexual dysfunction drug Addyi in the U.S. Electronics retailer Best Buy Co., Inc. Wednesday issued guidance for first-quarter adjusted earnings and revenues, below market estimates. Comparable sales are expected to be weak. For fiscal 2018, the company projects higher revenues and operating income. In its fourth quarter, the company posted higher profit, above market view, while revenues missed estimates with lower comparable sales.
comments powered by Disqus
Follow RTT